Immunotherapy for Post‐Transplant Lymphoproliferative Disease
- 1 September 2002
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 118 (3) , 728-740
- https://doi.org/10.1046/j.1365-2141.2002.03594.x
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Detection of EBV DNA in the cord blood donor for a patient developing Epstein–Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantationBone Marrow Transplantation, 2001
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter studyTransplant International, 2000
- Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantationTransplant International, 2000
- B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeBone Marrow Transplantation, 1999
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Donor T Cells to Treat EBV-Associated LymphomaNew England Journal of Medicine, 1994
- PATTERNS OF EPSTEIN-BARR VIRUS LATENT AND REPLICATIVE GENE EXPRESSION IN EPSTEIN-BARR VIRUS B CELL LYMPHOPROLIFERATIVE DISORDERS AFTER ORGAN TRANSPLANTATIONTransplantation, 1994
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984